Personal information

Other IDs

Scopus Author ID: 57073605700

Activities

Collapse all

Employment (1)

Medical University of Vienna: Vienna, AT

Employment
Source: Self-asserted source
Venugopal Gudipati

Works (15)

CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation.

Journal for immunotherapy of cancer
2024-02-27 | Journal article
DOI: 10.1136/jitc-2023-008155
PMID: 38417916
PMC: PMC10900364
Contributors: Jiri Eitler; Rackwitz W; Wotschel N; Gudipati V; Murali Shankar N; Sidorenkova A; Johannes Huppa; Ortiz-Montero P; Opitz C; Künzel SR et al.
Source: Self-asserted source
Venugopal Gudipati

Lower magnitude and faster waning of antibody responses to SARS-CoV-2 vaccination in anti-TNF-α-treated IBD patients are linked to lack of activation and expansion of cTfh1 cells and impaired B memory cell formation

eBioMedicine
2023-10 | Journal article
DOI: 10.1016/j.ebiom.2023.104788
Part of ISSN: 2352-3964
Contributors: Erika Garner-Spitzer; Angelika Wagner; Venugopal Gudipati; Anna-Margarita Schoetta; Maria Orola-Taus; Michael Kundi; Renate Kunert; Patrick Mayrhofer; Johannes B. Huppa; Hannes Stockinger et al.
Source: Self-asserted source
Venugopal Gudipati

The frequency of differentiated CD3+CD27-CD28- T cells predicts response to CART cell therapy in diffuse large B-cell lymphoma

Frontiers in Immunology
2023-01-09 | Journal article
DOI: 10.3389/fimmu.2022.1004703
Part of ISSN: 1664-3224
Contributors: Nina Worel; Katharina Grabmeier-Pfistershammer; Bernhard Kratzer; Martina Schlager; Andreas Tanzmann; Arno Rottal; Ulrike Körmöczi; Edit Porpaczy; Philipp B. Staber; Cathrin Skrabs et al.
Source: Self-asserted source
Venugopal Gudipati

Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial.

Nature communications
2022-09-12 | Journal article
DOI: 10.1038/s41467-022-33036-y
PMID: 36097029
PMC: PMC9467419
Contributors: Venugopal Gudipati
Source: Self-asserted source
Venugopal Gudipati

EBAG9 silencing exerts an immune checkpoint function without aggravating adverse effects.

Molecular therapy : the journal of the American Society of Gene Therapy
2022-07-12 | Journal article
DOI: 10.1016/j.ymthe.2022.07.009
PMID: 35821635
Contributors: Venugopal Gudipati
Source: Self-asserted source
Venugopal Gudipati

SARS-CoV-2-Specific Antibody (Ab) Levels and the Kinetic of Ab Decline Determine Ab Persistence Over 1 Year

Frontiers in Medicine
2022-02-15 | Journal article
DOI: 10.3389/fmed.2022.822316
Part of ISSN: 2296-858X
Contributors: Erika Garner-Spitzer; Angelika Wagner; Michael Kundi; Hannes Stockinger; Anna Ohradanova-Repic; Laura Gebetsberger; Anna-Margarita Schoetta; Venugopal Gudipati; Johannes B. Huppa; Renate Kunert et al.
Source: Self-asserted source
Venugopal Gudipati

Characterization of CD8 T Cell-Mediated Mutations in the Immunodominant Epitope GP33-41 of Lymphocytic Choriomeningitis Virus

Frontiers in Immunology
2021-06-14 | Journal article
DOI: 10.3389/fimmu.2021.638485
Part of ISSN: 1664-3224
Source: Self-asserted source
Venugopal Gudipati

SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8 + T cell responses

Science Immunology
2021-03-04 | Journal article
DOI: 10.1126/sciimmunol.abg6461
Contributors: Benedikt Agerer; Maximilian Koblischke; Venugopal Gudipati; Luis Fernando Montaño-Gutierrez; Mark Smyth; Alexandra Popa; Jakob-Wendelin Genger; Lukas Endler; David M. Florian; Vanessa Mühlgrabner et al.
Source: check_circle
Crossref

Getting CD19 Into Shape: Expression of Natively Folded “Difficult-to- Express” CD19 for Staining and Stimulation of CAR-T Cells

Frontiers in Bioengineering and Biotechnology
2020 | Journal article
DOI: 10.3389/fbioe.2020.00049
EID:

2-s2.0-85079760803

Part of ISBN:

22964185
Contributors: Lobner, E.; Wachernig, A.; Gudipati, V.; Mayrhofer, P.; Salzer, B.; Lehner, M.; Huppa, J.B.; Kunert, R.
Source: Self-asserted source
Venugopal Gudipati via Scopus - Elsevier

Inefficient CAR-proximal signaling blunts antigen sensitivity.

Nature immunology
2020-07-06 | Journal article
DOI: 10.1038/s41590-020-0719-0
PMID: 32632291
Source: Self-asserted source
Venugopal Gudipati
grade
Preferred source (of 2)‎

Catalytic competence, structure and stability of the cancer-associated R139W variant of the human NAD(P)H:quinone oxidoreductase 1 (NQO1)

FEBS Journal
2017 | Journal article
DOI: 10.1111/febs.14051
EID:

2-s2.0-85017371738

Part of ISBN:

17424658 1742464X
Contributors: Lienhart, W.-D.; Strandback, E.; Gudipati, V.; Koch, K.; Binter, A.; Uhl, M.K.; Rantasa, D.M.; Bourgeois, B.; Madl, T.; Zangger, K. et al.
Source: Self-asserted source
Venugopal Gudipati via Scopus - Elsevier

Collapse of the native structure caused by a single amino acid exchange in human NAD(P)H:Quinone oxidoreductase

FEBS Journal
2014 | Journal article
DOI: 10.1111/febs.12975
EID:

2-s2.0-84915758720

Part of ISBN:

17424658 1742464X
Contributors: Lienhart, W.-D.; Gudipati, V.; Uhl, M.K.; Binter, A.; Pulido, S.A.; Saf, R.; Zangger, K.; Gruber, K.; Macheroux, P.
Source: Self-asserted source
Venugopal Gudipati via Scopus - Elsevier

The flavoproteome of the yeast Saccharomyces cerevisiae

Biochimica et Biophysica Acta - Proteins and Proteomics
2014 | Journal article
DOI: 10.1016/j.bbapap.2013.12.015
EID:

2-s2.0-84892724850

Part of ISBN:

15709639 18781454
Contributors: Gudipati, V.; Koch, K.; Lienhart, W.-D.; Macheroux, P.
Source: Self-asserted source
Venugopal Gudipati via Scopus - Elsevier

The human flavoproteome

Archives of Biochemistry and Biophysics
2013 | Journal article
DOI: 10.1016/j.abb.2013.02.015
EID:

2-s2.0-84877028126

Part of ISBN:

00039861 10960384
Contributors: Lienhart, W.-D.; Gudipati, V.; MacHeroux, P.
Source: Self-asserted source
Venugopal Gudipati via Scopus - Elsevier

E3 ubiquitin ligases and plant innate immunity

Journal of Experimental Botany
2009 | Journal article
DOI: 10.1093/jxb/erp059
EID:

2-s2.0-64949143911

Part of ISBN:

00220957 14602431
Contributors: Craig, A.; Ewan, R.; Mesmar, J.; Gudipati, V.; Sadanandom, A.
Source: Self-asserted source
Venugopal Gudipati via Scopus - Elsevier
How many people are using ORCID?